These ASX 200 shares have been picked out as best buys for 2025 by analysts at Bell Potter. Let's see why it is ...

Quadrant Future Tek IPO GMP signals a strong debut of shares. Analysts also expect Quadrant Future Tek IPO listing to happen ...

Stock market headlines mostly seem to be about AI, EVs or political themes like "the Trump trade" these days. Equities' quiet sibling, bonds, rarely grab the spotlight. They are supposed to be boring.

Nevertheless, growth stocks outperformed value stocks in 2024, and investors anticipate that trend will continue as the ...

Stocks seesawed between gains and losses on Tuesday as investors digested a surprisingly soft wholesale inflation report and awaited more inflation data on Wednesday.

Strength in data center GPUs, networking, services, and emerging products fortify Nvidia's competitive 'moat' This article is the first in a series where tech-company analyst Ryan Shrout evaluates ...

I won’t be the first investor to admit that I missed out on the generational gains to be had from shares of Tesla (NASDAQ:TSLA) over the past five years. Undoubtedly, over the timespan, TSLA stock has ...

Compass Diversified offers a solid opportunity for income investors, trading at an attractive valuation with a near-5% yield ...

Jefferies analyst Blayne Curtis remains bullish on Broadcom and Marvell. He expects AVGO and MRVL to benefit from demand for custom AI chips.

Drops for Eli Lilly and other influential companies are weighing on U.S. indexes Tuesday, even though most of the market is ...

We recently published a list of Billionaire George Soros Stock Portfolio: Top 10 Stock Picks. In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other ...

Lilly revised its revenue guidance down 5%, to $13.5 billion, missing consensus of $14 billion by $500 million. But the guidance still represents a 45% increase from the same quarter in 2023. Lilly ...